Stryker hip implant recall adds more patients: 3 things to know

Kalamazoo, Mich.-based Stryker is extending the range of its settlement program to include patients who underwent procedures to remove the recalled implants since Nov. 3, 2014.

Advertisement

Here’s what you should know.

 

1. Several hundreds of people will be able to obtain compensation for the removal of the recalled Rejuvenate and ABGII modular hip implants.

 

2. The implants recalled in 2012 had a high failure rate associated with metallic corrosion. The related debris was causing tissue and muscle damage requiring complex revision surgeries.

 

3. The current settlement program is for litigation in New Jersey and Minnesota as well as for individual cases.

 

More orthopedic/spinal device news:
Providence Medical Technology receives $10.5M new equity financing — 5 points
Stavros Vizirgianakis to lead Misonix as new president, CEO: 5 things to now
NuVasive US Commercial President Matthew Link sells 10.3k shares: 5 key points

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.